Inovio Therapeutic Vaccine for Head & Neck and Other HPV-Related Cancers ... Bradenton Herald This vaccine is complementary to Inovio's VGX-3100, a therapeutic vaccine targeting cervical dysplasias and cancers caused by HPV types 16 and 18, which is in a phase II clinical study for CIN 2/3. This positive animal data mirrors the similarly robust ... Inovio's SynCon For HPV-related Cancers Induces Robust T-Cell Immune Response INOVIO PHARMACEUTICALS, INC. : Inovio Therapeutic Vaccine for Head & Neck and ... |
Monday, March 5, 2012
Inovio Therapeutic Vaccine for Head & Neck and Other HPV-Related Cancers ... - Bradenton Herald
lamoreuuceses1724.blogspot.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment